HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+14.45%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$3.02B
AUM Growth
+$3.02B
(-0.92%)
Cap. Flow
-$333M
Cap. Flow
% of AUM
-11.05%
Top 10 Holdings %
Top 10 Hldgs %
49.86%
Holding
57
New
11
Increased
11
Reduced
17
Closed
14
Top Buys
| 1 |
Stryker
SYK
|
$137M |
| 2 |
Cigna
CI
|
$125M |
| 3 |
AGN
Allergan plc
AGN
|
$105M |
| 4 |
CVS Health
CVS
|
$101M |
| 5 |
Medtronic
MDT
|
$92.7M |
Top Sells
| 1 |
Baxter International
BAX
|
$133M |
| 2 |
Merck
MRK
|
$126M |
| 3 |
Thermo Fisher Scientific
TMO
|
$114M |
| 4 |
Elevance Health
ELV
|
$102M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$90.9M |
Sector Composition
| 1 | Healthcare | 88.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zimmer Biomet
ZBH
$21B
| $279M | 9.27% | 2,125,000 +200,000 | +10% | +$26.3M |
|
|
2
Merck
MRK
$210B
| $171M | 5.67% | 2,408,880 -1,775,280 | -42% | -$126M |
|
|
3
Medtronic
MDT
$119B
| $166M | 5.51% | 1,689,850 +942,580 | +126% | +$92.7M |
|
|
4
Regeneron Pharmaceuticals
REGN
$61.5B
| $162M | 5.36% | 400,000 -225,000 | -36% | -$90.9M |
|
|
5
Stryker
SYK
$150B
| $155M | 5.16% | 875,000 +768,710 | +723% | +$137M |
|
|
6
Cigna
CI
$80.3B
| $125M | 4.14% | +600,000 | New | +$125M |
|
7
HCA Healthcare
HCA
$94.5B
| $118M | 3.92% | 850,000 -350,000 | -29% | -$48.7M |
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $117M | 3.9% | 616,660 +550,450 | +831% | +$105M |
|
9
Labcorp
LH
$23.1B
| $106M | 3.5% | 608,257 -291,743 | -32% | -$50.7M |
|
10
Intuitive Surgical
ISRG
$170B
| $104M | 3.44% | 180,460 +4,450 | +3% | +$2.55M |
|
|
11
CVS Health
CVS
$92.8B
| $101M | 3.34% | +1,279,760 | New | +$101M |
|
12
Pacira BioSciences
PCRX
$1.2B
| $95.6M | 3.17% | 1,945,540 -909,673 | -32% | -$44.7M |
|
13
UnitedHealth
UNH
$281B
| $92.7M | 3.08% | 348,520 -58,380 | -14% | -$15.5M |
|
14
LivaNova
LIVN
$3.08B
| $86.2M | 2.86% | 695,110 -104,890 | -13% | -$13M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $83.8M | 2.78% | 936,168 -16,502 | -2% | -$1.48M |
|
|
16
Elevance Health
ELV
$71.8B
| $83.4M | 2.77% | 304,270 -370,730 | -55% | -$102M |
|
17
Quest Diagnostics
DGX
$20.3B
| $79.4M | 2.63% | 735,930 -261,650 | -26% | -$28.2M |
|
18
Edwards Lifesciences
EW
$47.8B
| $79M | 2.62% | +453,715 | New | +$79M |
|
|
HRC
19
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $76.3M | 2.53% | +807,760 | New | +$76.3M |
|
20
DexCom
DXCM
$29.5B
| $67.9M | 2.25% | 474,680 -139,950 | -23% | -$20M |
|
|
RDUS
21
DELISTED
Radius Health, Inc.
RDUS
| $63.8M | 2.12% | 3,584,580 +1,559,580 | +77% | +$27.8M |
|
|
AERI
22
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $63.5M | 2.11% | 1,032,127 -282,163 | -21% | -$17.4M |
|
23
Madrigal Pharmaceuticals
MDGL
$9.76B
| $56.3M | 1.87% | 262,860 +65,579 | +33% | +$14M |
|
|
XENT
24
DELISTED
Intersect ENT, Inc
XENT
| $56.1M | 1.86% | 1,950,000 +681,150 | +54% | +$19.6M |
|
25
Boston Scientific
BSX
$156B
| $54M | 1.79% | 1,402,950 +695,090 | +98% | +$26.8M |
|